Northwest Biotherapeutics (NWBO) FCF Margin Growth (1y) (2011 - 2026)
Northwest Biotherapeutics (NWBO) FCF Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,187.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Northwest Biotherapeutics | 253,653.43 | -1.53 Mn | - | -2,203.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,203.00 |
| Dec 31, 2025 | 643,843.00 |
| Sep 30, 2025 | -469,204.00 |
| Jun 30, 2025 | -205,937.00 |
| Mar 31, 2025 | 191,620.00 |
| Dec 31, 2024 | -486,541.00 |
| Sep 30, 2024 | 118,050.00 |
| Jun 30, 2024 | 307,519.00 |
| Mar 31, 2024 | -302,383.00 |
| Dec 31, 2023 | -206,067.00 |
| Sep 30, 2023 | 442,229.00 |
| Jun 30, 2023 | -315,638.00 |
| Mar 31, 2023 | 180,337.00 |
| Sep 30, 2022 | -518,568.00 |
| Jun 30, 2022 | -120,190.00 |
| Mar 31, 2022 | 242,155.00 |
| Sep 30, 2021 | 197,928.00 |
| Jun 30, 2021 | 37.67 Mn |
| Mar 31, 2021 | -432,005.00 |
| Dec 31, 2020 | -195,802.00 |